financetom
Business
financetom
/
Business
/
Goldman Sachs granted licence for China fund sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Goldman Sachs granted licence for China fund sales
Dec 13, 2024 5:28 AM

HONG KONG, Dec 13 (Reuters) - Goldman Sachs ( GS )

received regulatory approval to sell funds in China, the latest

U.S. investment bank to get a financial licence in a sign of

Beijing's commitment to continue opening up the sector to

foreign companies.

The Beijing Bureau of China Securities Regulatory Commission

(CSRC) granted a fund sales licence to the U.S. bank's Chinese

securities brokerage unit on Friday, an official record shows.

The approval comes after China's top economic and financial

leaders recently voiced continued support to international

companies' China expansion.

The CSRC granted rival U.S. investment bank Morgan Stanley ( MS )

a futures licence in China last month.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gold miners Predictive Discovery, Robex to merge in $1.5 billion deal
Gold miners Predictive Discovery, Robex to merge in $1.5 billion deal
Oct 6, 2025
DAKAR, Oct 6 (Reuters) - Australian miner Predictive Discovery ( PDIYF ) and Canada's Robex Resources ( RSRBF ) said they will merge in a A$2.35 billion ($1.55 billion) all-share deal, creating a mid-tier gold producer in West Africa. Under the deal, Robex shareholders will receive 8.667 Predictive shares for each Robex share, giving them about 49% ownership of the...
Alvotech, Advanz Pharma Say Europe Accepts Marketing Application for Asthma Drug Biosimilar
Alvotech, Advanz Pharma Say Europe Accepts Marketing Application for Asthma Drug Biosimilar
Oct 6, 2025
05:20 AM EDT, 10/06/2025 (MT Newswires) -- Alvotech ( ALVO ) and Advanz Pharma said Monday that the European Medicines Agency has accepted a marketing authorization application for AVT23, a proposed biosimilar to Xolair, or omalizumab, a drug used to control allergy-related asthma. The drug is also used to treat long-term itchy rash and inflamed lining of the nose and...
Danaos Plans $500 Million Private Debt Offering; Shares Up Pre-Bell
Danaos Plans $500 Million Private Debt Offering; Shares Up Pre-Bell
Oct 6, 2025
05:17 AM EDT, 10/06/2025 (MT Newswires) -- Danaos ( DAC ) said Monday it plans a private offering of up to $500 million of senior notes due 2032, subject to market conditions and other factors. The company intends to use the net proceeds to fully redeem the $262.8 million outstanding principal amount of its 8.5% senior notes due 2028 on...
European major satellite venture still needs some time to finalise, source says
European major satellite venture still needs some time to finalise, source says
Oct 6, 2025
ROME/PARIS, Oct 6 (Reuters) - A framework agreement between France's Airbus and Thales and Italy's Leonardo to create a major new European satellite manufacturer will still require some weeks, a source told Reuters on Monday. The person familiar with the matter said key details remain under discussion and that the boards of the three companies are working to reach a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved